This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Pulmonary Hypertension: A Patient-Centered, Team-based Approach to Optimizing Outcomes in PAH and CTEPH

Pulmonary Hypertension: A Patient-Centered, Team-based Approach to Optimizing Outcomes in PAH and CTEPH

Format

Webcast

Time to Complete

45 minutes

Released

November 15, 2018

Expires

November 15, 2019
Add to Queue


Maximum Credits

0.75 / AMA PRA Category 1 CreditTM
0.80 / CNE Contact Hours (0.10 pharmacotherapy hours)
0.80 / CE for Pharmacists (0.08 CEUs)

Accredited Provider

Jointly provided by Integrity Continuing Education and Postgraduate Institute for Medicine.

Commercial Supporter

Supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.

Program Description

PH is a disorder of the pulmonary vasculature and complication of many chronic diseases that is estimated to affect 10% to 20% of the general population. Both conditions involve chronically elevated pressure in the pulmonary arteries that can eventually lead to right-sided heart failure. Morbidity and mortality are poor among patients with PAH or CTEPH, particularly with no therapeutic intervention. The overlaps in clinical features and important differences (and similarities) in treatment between these disorders requires that healthcare providers must have a keen understanding of early diagnostic and evidence-based treatment approaches for each disorder to optimize outcomes in these patients.

Intended Audience

This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify strategies to screen and improve early recognition of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
  • Apply guideline recommendations to the accurate diagnosis of PAH and CTEPH
  • Develop a guideline-directed, evidence-based management plan for PAH and CTEPH that includes consideration of novel therapies and current clinical trial data
  • Establish a multidisciplinary, patient-centered approach to care for patients with PAH or CTEPH

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. and Postgraduate Institute for Medicine require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Postgraduate Institute for Medicine are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

Faculty

Ioana R. Preston, MD, FACCP
Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Tufts Medical Center
Boston, Massachusetts

Dr. Preston discloses the following:
Consultant: Acceleron, Actelion, Gilead, Liquidia, Pfizer, United Therapeutics
Grants to TMC: Acceleron, Actelion, Bayer, Complexa, Gilead, Liquidia, United Therapeutics

Accredited Provider Disclosure

The following planner and manager, Michelle R. Rizzo, ELS, hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. The PIM planners and managers have nothing to disclose.

Credit

0.75

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.80

Type

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integrity Continuing Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.80 contact hours. Designated for 0.10 hours of pharmacotherapy for Advance Practice Registered Nurses.

Credit

0.80

Type

CE for Pharmacists

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integrity Continuing Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Postgraduate Institute for Medicine designates this continuing education activity for a total of 0.80 contact hour(s) (0.08 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008162-9999-18-416-H01-P)
Type of Activity: Application

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Postgraduate Institute for Medicine, and Actelion Pharmaceuticals US, Inc., do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Postgraduate Institute for Medicine, and Actelion Pharmaceuticals US, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of November 15, 2018 through November 15, 2019, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A certificate will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or higher. Please proceed with the activity until you have successfully passed the post-test, completed the evaluation and received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc., at (855) 835-4004 or information@integrityce.com.

For questions related to the ACPE or ANCC accreditation of this activity, please contact Postgraduate Institute for Medicine at information@pimed.com or (303) 799-1930

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue